Abstract

The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing (AST) develops and publishes standards and guidelines for AST methods and results interpretation in an annual update to the Performance Standards for Antimicrobial Susceptibility Testing (M100). This minireview will discuss changes to M100 for the 31st edition, including new and revised breakpoints and testing recommendations.

Affiliated Institutions

Related Publications

Quality Control Guidelines for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Disk Diffusion Susceptibility Tests with Nonsupplemented Mueller-Hinton Agar (CLSI M51-A Document) for Nondermatophyte Filamentous Fungi

ABSTRACT Although Clinical and Laboratory Standards Institute (CLSI) disk diffusion assay standard conditions are available for susceptibility testing of filamentous fungi (mold...

2011 Journal of Clinical Microbiology 73 citations

Publication Info

Year
2021
Type
article
Volume
59
Issue
12
Pages
e0021321-e0021321
Citations
1310
Access
Closed

External Links

Citation Metrics

1310
OpenAlex

Cite This

Romney Humphries, April M. Bobenchik, Janet A. Hindler et al. (2021). Overview of Changes to the Clinical and Laboratory Standards Institute <i>Performance Standards for Antimicrobial Susceptibility Testing,</i> M100, 31st Edition. Journal of Clinical Microbiology , 59 (12) , e0021321-e0021321. https://doi.org/10.1128/jcm.00213-21

Identifiers

DOI
10.1128/jcm.00213-21